L'incidence, le coût et l'issue fatale dans un nombre encore trop élevé de cas font du cancer un problème majeur en santé publique. Malgré les progrès réalisés dans le développement de thérapies ciblées, la plupart des cancers rechutent, vraisemblablement à cause de l'échappement des cellules souches cancéreuses (CSC) qui survivent et régénèrent la tumeur. L'enjeu clinique en cancérologie aujourd'hui est d'éliminer les cellules souches cancéreuses en épargnant les cellules souches normales. Pour atteindre cet objectif, il est primordial de comprendre leurs mécanismes spécifiques de transformation. Nous évaluons dans mon équipe de recherche l'implication du microenvironnement dans la transformation et la résistance des CSC épithéliales, à travers les effets de facteurs solubles et de contacts cellulaires : l'enzyme CD10, et la voie des BMPs (Bone Morphogenetic Proteins).Notre équipe étudie le rôle du dialogue permanent entre la CS normale et son microenvironnement qui régule la prolifération, et la survie des CS. Nous utilisons la glande mammaire et la prostate comme systèmes modèles car ces deux types d'épithélium présentent des similitudes, ce qui nous permet d'aborder la question de l'apparition et la résistance des CSC dans deux modèles tumoraux correspondants. Des dérégulations de la voie des BMPs, comme de l'enzyme CD10 sont observées dans ces tumeurs. Enfin, nous cherchons à comprendre comment les dérégulations de la voie des BMPs apparaissent, en s'intéressant principalement aux facteurs pouvant modifier directement le microenvironnement, tels que les polluants présents dans l'environnement (bisphénols, benzoapyrène) / It has been shown for a number of cancers that a cell population characterized by stem cell (SC) properties and therapeutic resistance is likely responsible for relapse several years after treatment. Current therapies kill most of the tumor cells, but fail to eradicate the so-called cancer stem cells (CSC). Therefore a complete cure of the disease will require the eradication of the tumor-sustaining CSC. We propose to study these CSC in the context of breast cancer as the existence of CSC as already been highlighted in this epithelia.CD10 is a membrane enzyme able to cleave several peptide of the microenvironment (such as oxytocin, bombesin, enkephalin.. ) that can also interact with intracellular signalling pathway through its direct interaction with PTEN. Our results, and those of the literature, indicate that CD10 enzyme controls the fate of SC and is deregulated in normal breast and cancerous tissues. We showed that CD10 membrane expression allows the maintenance of immature cells partly through its enzymatic function that inhibits mammary stem cells differentiation. As CD10 has been described in breast cancer initiation, progression and resistance, we then decided to test the role of CD10 in tumor context. Our strategy consists in flow cytometry cell sorting for CD10+/CD10- cells to compare the functional properties of both sub-population. Only CD10+ cells are able to regenerate both CD10+ and CD10- subpopulations, and CD10+ cells exhibit higher expression of immature genes. Interestingly, modulating CD10 using stable expression of CD10 in our models and Sh strategies do not mimick the normal functions of CD10, indicating that CD10 could be more a marker of a certain population with immature properties prone to transformation rather than a driver. To better characterize the role of CD10 in luminal breast transformation, we developed a new human mammary model, initiated from immature cells to obtain transformed luminal epithelial cells and their resistant counterpart. We observed a higher level of CD10 expression during mammary epithelial cell transformation process. We then performed a microarray on CD10+ and CD10- subpopulations. Preliminary analysis seems to confirm that CD10 is a potential marker for a stem cell population prone to transformation rather than a direct driver of the cell transformation

Das Bone Morphogenetic Protein 2 (BMP2) gehört zur TGF-beta Superfamilie und findet seinen Fokus in der osteogenen Aktivierung und in der Anwendung bei der Frakturheilung. Es wird angenommen, dass weitere, bisher unbekannte Verbindungen existieren, die die BMP2-Signalübertragung und die osteogene Aktivität verbessern und somit zu einer verbesserten klinischen Wirksamkeit von BMP2 führen. Für den Stickstoffoxid (NO)-Signalweg ist bereits bekannt, dass im endothelialen Kontext eine Verbindung zum BMP2-Signalweg existiert. Ziel dieser Arbeit war es daher, eine Verbindung zwischen dem NO- und BMP2-Signalweg bezüglich der Regulierung des BMP2-abhängigen Signalwegs und der Osteoinduktion aufzuzeigen. Dies erfolgte durch Anwendung von Inhibitoren (LNAME, ODQ und LY83583) und Aktivatoren (L-Arginin, Deta NONOate, SNAP und YC-1) des NO-Signalwegs, in Kombination mit BMP2. Eine mögliche Verbindung zwischen dem BMP2- und NO-Signalweg, über eine Protein Kinase A (PKA) Brücke, wurde durch die Anwendung des PKA Inhibitors H89 untersucht. Zusammenfassend zeigen diese Ergebnisse, dass der NO-Stoffwechselweg den BMP2-vermittelten Signalweg und die osteoinduktive Aktivität modulieren kann, wobei PKA beide Signalwege im Rahmen der BMP Signalübertragung verbindet, jedoch nicht zu einer BMP2-vermittelten Osteoinduktion führt. / Bone Morphogenetic Protein 2 (BMP2) is a TGF-beta superfamily member, with a major focus on osteogenic activity and application in fracture healing. In order to improve efficiency of BMP2 in the clinic, it is assumed that additional, yet unknown compounds can improve BMP2 signalling and osteogenic activity. The Nitric Oxide (NO) pathway has previously shown to be connected with the BMP2 pathway in an endothelial context. Therefore, it was the aim of this study to unravel connections between the NO and BMP2 pathway in regulating BMP2 mediated signalling and osteoinduction. This was carried out through the application of inhibitors (LNAME, ODQ and LY83583) and activators (L-Arginine, Deta NONOate, SNAP and YC-1) of the NO pathway in combination with BMP2. A proposed connection between BMP2 and NO pathways via a Protein Kinase A (PKA) bridge was investigated by application of H89 inhibitor. In summary, these results show that the NO pathway can modulate BMP2 mediated signalling and osteoinductive activity. The PKA bridge connects NO and BMP2 only for the process of BMP2 signalling, but not for BMP2 mediated osteoinduction.

No description available.

Une des principales causes d’échec dans le traitement des cancers est le développement de résistances aux drogues par les cellules tumorales. Les cellules souches cancéreuses (CSC) sont suspectées d’être responsables de ces rechutes, conduisant à la récurrence de la maladie et bien souvent au décès des patients. En clinique, il est donc nécessaire de développer des stratégies thérapeutiques capables de cibler ces CSC résistantes et aboutir à la guérison des patients. Les CSC sont régulées par un ensemble de signaux aussi bien biologiques que physiques au sein de la niche tumorale. Mon projet a pour objectif de déterminer l’implication du microenvironnement tumoral (voie de signalisation BMP et contraintes mécaniques) dans le maintien et la résistance des cellules souches leucémiques (CSLs) de la leucémie myéloïde chronique (LMC). Pour cela, nous avons combiné tests fonctionnels et moléculaires ainsi que l’analyse de la niche tumorale sur plus de 200 échantillons de patients atteints de LMC. Nous avons ainsi démontré que l’altération de la voie BMP intrinsèque aux cellules immatures de la LMC corrompt et amplifie la réponse à BMP2 et BMP4, présents en quantités anormalement abondantes au sein de la niche tumorale. Ces résultats récemment publiés dans Blood nous ont amenés à évaluer le rôle de la voie BMP dans le maintien des CSLs sous traitement par les ITK. La microscopie à force atomique nous a permis de démontrer que l’expression de BCR-ABL est suffisante pour induire une augmentation de la rigidité des cellules immatures de LMC par rapport à des cellules saines. Enfin, l’utilisation d’un système de confinement cellulaire nous a permis de démontrer que le stress mécanique contrôle la prolifération des cellules leucémiques immatures en régulant l’expression de gènes mécano-sensibles comme Twist-1. Ces résultats pourraient expliquer comment des CSLs tirent profit des contraintes mécaniques issues de leur microenvironnement afin d’acquérir un avantage prolifératif par rapport aux cellules saines. Ultimement, nous espérons que cette approche transdisciplinaire permettra d’identifier les molécules clés de la transduction de signaux mécaniques potentiellement impliqués dans le maintien et la résistance des CSC et ainsi proposer de nouvelles cibles pour contrer ces effets. / One of the main causes of treatment failure in cancers is the development of drug resistance by cancer cells. The persistence of cancer stem cells (CSCs) might explain cancer relapses as they could allow reactivation of cancer cells proliferation following therapy, leading to disease persistence and ultimately to patients’ death. Clinically, it is crucial to develop therapeutic strategies able to target resistant CSCs in order to cure the patients. CSCs are controlled by a variety of biochemical and biomechanical signals from the leukemic niche. My project aims to determine the involvement of the tumor microenvironment (BMP signaling pathway and mechanical stress) in the maintenance and resistance of Leukemic Stem Cells (LSCs) in Chronic Myelogenous Leukemia (CML). For this, we combined functional and molecular assays to the analysis of tumor microenvironment on more than 200 CML patients’ samples. We demonstrated that alterations of intracellular BMP signaling pathway in CP-CML primary samples corrupt and amplify the response to exogenous BMP2 and BMP4, which are abnormally abundant in the tumor microenvironment. These results, recently published in Blood led us to evaluate the role of the BMP pathway in LSC maintenance under TKI treatment. Atomic force microscopy allowed us to demonstrate that BCR-ABL expression alone is sufficient to increases the rigidity of immature CML cells compared to healthy ones. Finally, using a unique cell confining system, we were able to demonstrate that mechanical stress controls the proliferation of immature leukemic cells by regulating the expression of mechano-sensitive genes such as Twist-1. These results could explain how LSCs can benefit from a mechanical stress exerted by their microenvironment to acquire a proliferative advantage over normal cells. Ultimately, we hope that this transdisciplinary approach will help to identify key molecules in the transduction of mechanical signals potentially involved in maintenance and resistance of CSCs and thus offer new targets to counter these effects.

Nous avons déterminé la capacité de régénération du tissu vasculaire in vivo des CSM traitées avec BMP2 à la dose de [100 ng.mL-1] dans un modèle rat. Nous avons ainsi rapporté qu’une prothèse revêtue de CSM traitée par BMP2 pendant 1 semaine et implantée 14 jours chez le rat permettait la reconstitution des trois tuniques de la paroi mimant la structure de l’aorte. La capacité proangiogénique des CSM était augmentée par BMP2 grâce à la mise en jeu de voies intracellulaires impliquant le facteur induit par l’hypoxie (HIF-1α) via JAK/STATs. Nous avons montré que les CSM migraient sous l’influence de BMP2 par stimulation de l’activité du complexe enzymatique NADPH oxydase via l’augmentation de l’expression des protéines PAK1, Vav2 et RAC1 GTPase/PI3K. Ce travail a confirmé l’intérêt de l’utilisation de CSM conjointement à rh-BMP2, une protéine impliquée dans l’embryogénèse vasculaire, pour la bioingénierie de la régénération vasculaire. / We determined the capacity to regenerate vascular tissue in vivo, of MSC treated with BMP2 at a dose of [100 ng.mL-1] in a rat model. We have reported that a prosthesis coated with CSM treated 1 week with BMP2 and implanted in rats 14 days allowed the reconstruction of the three tunics of the wall that mimic the structure of the aorta. The proangiogenic capacity of MSCs was increased by BMP2 through the intracellular pathways involving hypoxia inducible factor (HIF-1α) via JAK / STAT. We have shown that MSCs migrated under the influence of BMP2 by stimulating the activity of the enzyme complex NADPH oxidase via the increased expression of PAK1 protein, Vav2 and RAC1 GTPase/PI3K. This work confirmed the interest of the use of MSC in conjunction with rh-BMP2, a protein involved in vascular embryogenesis for bioengineering for vascular regeneration.

Vascular remodelling due to excessive proliferation and apoptosis resistance of pulmonary arterial smooth muscle (PASMCs) and endothelial cells (ECs) has been attributed to the pathogenesis of pulmonary arterial hypertension (PAH). It is an incurable cardiovascular disorder, which leads to right heart failure and death, if left untreated. Heterozygous germline mutations in the bone morphogenetic protein receptor type II (BMPR2) have been linked with the majority (~75%) of the familial form of the disease (HPAH). Mutations in the BMPR2 gene impinge upon the BMP signalling which perturbs the balance between BMP and TGF-β pathways leading to the clinical course of the disease. Current therapies were discovered prior to the knowledge that PAH has substantial genetic components. Hence, this study aims to identify novel therapeutic intervention and provide novel insights into how the dysfunctional BMPRII signalling contributes to the pathogenesis of PAH. This work demonstrates that cryptolepines and FDA approved drugs (doxorubicin, taxol, digitoxin and podophyllotoxin) inhibit the excessive proliferation and induce apoptosis in BMPR2 mutant PASMCs by modulating the BMP and TGF-β pathways. Moreover, established drug PTC124 has also been tested but has failed to promote translational readthrough. I have also shown that dysregulated apoptosis of PASMCs and HPAECs is mediated through the BMPRII-ALK1-BclxL axis. Finally, the siRNA screen targeting approximately 1000 genes has identified novel proteins including PPP1CA, IGF-1R, MPP1, MCM5 and SRC each capable of modulating the BMPRII signalling. Taken together, this study for the very first time has identified novel compounds with pro-BMP and anti-TGFβ activities which may provide therapeutic intervention prior to or after the onset of PAH. / Commonwealth Scholarship Commission in the UK / The full text will be available at the end of the embargo period, 31st July 2024.

No description available.

Na presença de fraturas, infecções ou tumores ósseos que ocasionem perda extensa de tecido ósseo, existe a necessidade da utilização de enxerto ósseo autólogo. Apesar deste método ser considerado o padrão-ouro, apresenta algumas desvantagens, como a morbidade da área doadora e limitação do volume a ser obtido. Alternativamente, são considerados como uma importante opção de tratamento, os implantes com biomateriais. Dentre eles, destacam-se as esponjas de colágeno, hidroxiapatita e proteína morfogenética óssea (BMP). A elastina atualmente esta sendo investigada como nova opção para substrato na regeneração tecidual. Assim, o objetivo deste projeto foi avaliar o processo de reparo de defeitos ósseos enxertados com estes biomateriais. Foram estudados 77 animais da seguinte forma: Grupo 1 (G1-C): ratos com defeito crítico induzido no osso femoral direito, sem preenchimento com implante (grupo controle). Grupo 2 (G2-E24/37): animais com defeito produzido no fêmur distal direito, preenchido com membrana de elastina 24h a 37ºC. Grupo 3 (G3-E24/37+HA): animais com defeito produzido no fêmur distal direito, preenchido com membrana de elastina 24h a 37ºC + hidroxiapatita. Grupo 4 (G4-E24/37+BMP): animais com defeito produzido no fêmur distal direito, preenchido com membrana de elastina 24h a 37ºC + BMP. Grupo 5 (G5-C24/25): animais com defeito produzido no fêmur distal direito, preenchido com membrana de colágeno da serosa de intestino porcino 24h a 25ºC. Grupo 6 (G6-C24/25+HA): animais com defeito produzido no fêmur distal direito, preenchido com membrana de colágeno da serosa de intestino porcino 24h a 25ºC + hidroxiapatita. Grupo 7 (G7-C24/25+BMP): animais com defeito produzido no fêmur distal direito, preenchido com membrana de colágeno da serosa de intestino porcino 24h a 25ºC + BMP. As análises demonstraram a biocompatibilidade das membranas devido a ausência de elementos celulares característicos de processo inflamatório. A membrana de elastina isolada ou associada a hidroxiapatita não apresentou resultados superiores ao grupo controle, apenas quando associada à BMP, o resultado foi superior ao controle. A membrana de colágeno isolada ou associada à BMP ou hidroxiapatita apresentaram resultados superiores ao controle. Os biomateriais estudados apresentaram capacidade osteogênica e houve osteointegração na falha óssea induzida experimentalmente. / Bone lesions as fractures, infections or bone tumors can cause extensive bone loss. In this scenario, the use of any type of bone augments is advocated. Although autollogus bone graft is considered the gold standard, some disadvantages are related with this method such as donor area morbidity and limited availability of graft material. Alternatively, implants with biomaterials are considered an important option. Among them, the sponges of collagen, hydroxyapatite and BMP show outstanding results. Elastin is currently being investigated as a new substrate option in tissue regeneration. Thus, the objective of this project was to evaluate the repair process of bone defects grafted with these biomaterials. A total of 77 animals were studied as follows: Group 1 (G1-C): rats with critical defect induced in the right femoral bone, without implant filling (control group). Group 2 (G2-E24/37): animals with defect produced in the right distal femur, filled with elastin membrane. Group 3 (G3-E24/37 + HA): animals with defect produced in the right distal femur, filled with elastin membrane plus hydroxyapatite. Group 4 (G4-E24/37 + BMP): animals with defect produced in the right distal femur, filled with elastin membrane plus BMP. Group 5 (G5-C24/25): animals with defect produced in the right distal femur, filled with porcine intestinal serosa collagen membrane. Group 6 (G6-C24/25 + HA): animals with defect produced in the right distal femur, filled with porcine intestine serous collagen membrane plus hydroxyapatite. Group 7 G7-C24/25 + BMP: animals with defect produced in the right distal femur, filled with porcine intestinal serosa collagen membrane plus BMP. The analyzes demonstrated the biocompatibility of the membranes due to the absence of cellular elements characteristic of inflammatory process. The elastin membrane isolated or associated with hydroxyapatite did not present superior results to the control group. The result was superior to the control only when elastin was associated with BMP. The collagen membrane isolated or associated with BMP or hydroxyapatite presented superior results to control. The studied biomaterials presented osteogenic capacity and osseointegration in experimentally induced bone failure.

Para testar a hipótese de que a desmineralização in situ das superfícies de contato enxerto-leito, e a forma como o enxerto é estabilizado ao leito, podem influenciar os mecanismos envolvidos na consolidação do enxerto, fragmentos ósseos de 10 mm de diâmetro foram removidos das metáfises proximais tibiais de 36 coelhos (Oryctolagus Cuniculus) e transplantados para uma área adjacente. Na tíbia esquerda dos animais, as superfícies de contato do enxerto e do leito hospedeiro foram desmineralizadas com ácido cítrico pH 1,0 por 3 minutos antes dos enxertos serem fixados ao leito. Na tíbia direita, o transplante do bloco ósseo não foi precedido de desmineralização. Metade dos enxertos foi imobilizada sobre o leito pela superposição de uma membrana não reabsorvível de politetrafluoretileno colada com cianoacrilato ao leito à distância da interface enxerto-leito. A outra metade dos enxertos foi fixada por um parafuso de titânio no centro do enxerto. Assim, foram formados 4 grupos de estudo: membrana (M), membrana + ácido (MA), parafuso (P) e parafuso + ácido (PA). Três animais de cada grupo forneceram espécimes para análise microscópica quantitativa e qualitativa aos 15, 30 e 45 dias de pós-operatório. A análise qualitativa demonstrou que não houve formação óssea na interface em nenhum espécime aos 15 dias e que nos demais períodos, em todos os grupos, a quantidade de tecido ósseo neoformado na interface e seu estágio de maturação aumentaram com o tempo. Ambos os métodos de fixação empregados foram eficientes em manter os enxertos em posição, porém a membrana promoveu menor reabsorção da estrutura do enxerto. A análise quantitativa computadorizada revelou que, aos 30 dias, os grupos MA e PA apresentaram maior área de formação óssea na interface (71,34 ± 12,03%; 56,74 ± 2,15% respectivamente) em relação aos grupos M e P (51,75 ± 11,02%; 43,95 ± 4,05% respectivamente) e superfícies de consolidação óssea mais extensas (93,41 ± 5,95%; 93,73 ± 4,96% respectivamente) do que os grupos sem tratamento ácido (73,49 ± 7,7%; 73,77 ± 11,77% respectivamente para M e P), sendo essas diferenças estatisticamente significantes (p<0,05). Aos 45 dias de pós-operatório, os grupos MA e PA (71,18 ± 8,9%; 58,97 ± 3,97% respectivamente) apresentaram resultados superiores aos grupos M e P (59,78 ± 11,28%; 46,08 ± 3,53% respectivamente) em relação à área de neoformação óssea na interface, porém essa diferença não foi significativa. Concluiu-se que a desmineralização ácida das superfícies contactantes nos enxertos ósseos autógenos em bloco na tíbia de coelhos promoveu a osteogênese na interface enxerto-leito e acelerou a consolidação dos enxertos. Além disso, quando o tratamento ácido foi associado ao uso de membrana como método de fixação, a consolidação e grau de reabsorção óssea foram otimizados. / In order to test the hypothesis that the demineralization \"in situ\" of contacting surfaces of bone graft/bone bed and the fixation method used for graft stabilization can influence the mechanisms involved in the consolidation of the graft, bone fragments of 10 mm in diameter were removed from the proximal tibial metaphysis of thirty-six male rabbits (Oryctolagus Cuniculus) and transplanted to an adjacent area. In the left tibia of the animals, the contacting surfaces of the graft and host bed were demineralized with citric acid pH 1.0 for 3 minutes before the grafts were fixed to the receptor bed. In the right tibia, the bone block transplantation was not preceded by demineralization. Half of the grafts were immobilized on the bone bed by a nonresorbable polytetrafluoroethylene membrane glued with cyanoacrylate adhesive to the host bed distant from the bone graft-bone bed interface. The other half of the grafts were fixed by a titanium screw in the center of the graft. Thus, four groups were formed: membrane (M), membrane + acid (MA), screw (P) and screw + acid (PA). Three animals from each group provided specimens for quantitative and qualitative microscopic analysis at 15, 30 and 45 days postoperatively. Qualitative analysis showed no significant bone formation at the interface in any specimen of the groups at 15 days and on the other periods in all groups, the amount of newly formed bone at the interface as well as the stage of bone maturation increased with time. Both fixation methods were effective in maintaining the graft in position, but the membrane resulted in less resorption of the graft. Quantitative analysis, performed by means of a computer program for image analysis, showed that at day 30, groups MA and PA, showed greater area of bone formation at the interface (71.34 ± 12.03%; 56.74 ± 2 15%) than groups M and P (51.75 ± 11.02%, 43.95 ± 4.05%) and more osseointegrated bone surfaces (93.41 ± 5.95%, 93.73 ± 4.96%) than those without acid treatment (73.49 ± 7.7%, 73.77 ± 11.77%), and these differences were statistically significant. At 45 days postoperatively MA and PA groups (71.18 ± 8.9%, 58.97 ± 3.97%) showed better results than the M and P groups (59.78 ± 11.28%, 46 , 08 ± 3.53%) compared to the area of new bone formation at the interface and osseointegrated surfaces, but these differences were not significant. It was concluded that the acid demineralization of contacting surfaces in autogenous onlay bone grafts in the tibia of rabbits promotes osteogenesis in bone graft-host bed interface and accelerates the consolidation of the grafts. Furthermore, the association of this surface treatment to the use of membrane/cyanoacrylate fixation method, optimizes the results regarding consolidation and degree of bone graft resorption.

O objetivo do atual trabalho, foi correlacionar os eventos celulares e teciduais com a expressão das proteínas VEGF, BMP-7, RANKL e OPG durante a osteogênese ectópica e ortotópica, induzida pela matriz óssea (MO) e dentinária (MD) alogênica. Matrizes alogênicas desmineralizada em HCl a 0,6N, obtidas de fêmur e incisivo de ratos, fori implantada entre as fáscias musculares da coxa e em defeito trans-ósseo de 8mm de diâmetro nos ossos parietais. As análises radiográfica e histomorfométrica da neoformação óssea e, a imunohistoquímica e o western blotting para as proteínas VEGF, BMP, RANKL e OPG, mostraram que: a) o volume da região do enxerto nos sítios ortotópicos reduziu 19% em 42 dias; b) em ambos tipos de enxerto e locais de implantação, ocorreu formação de tecido cartilaginoso e ósseo; c) nos sítios intramusculares, a reabsorção da matriz alogênica e a remodelação do tecido cartilaginoso, ósseo e medular foi mais acelerado, em relação a implantação ortotópico; d) o aumento na densidade de volume dos vasos sanguíneos e no número de osteoblastos/osteócitos e osteoclastos ocorreu simultaneamente e estava associado à maior reabsorção da matriz alogênica e à formação do tecido medular (hematopoiético); e) as proteínas VEGF, BMP-7, RANKL, OPG foram expressas em condrócitos, osteoblastos ativos, osteócitos recém aprisionados na matriz e em células estromais próximas aos osteoblastos ou às áreas da matriz alogênica reabsorvida; e f) a expressão das proteínas VEGF, BMP-7, RANKL e OPG foi maior no grupo MO. O pico de expressão dessas proteínas ocorreu nos períodos de 14 aos 21 dias no grupo da MO e 21 e 28 dias no grupo da MD. Concluímos que, a capacidade osteoindutora da matriz alogênica desmineralizada está relacionado a origem da matriz e ao sítio de implantação e que, as proteínas VEGF, BMP-7, RANKL e OPG estão associadas a maior reabsorção da matriz implantada, promovendo uma rápida e contínua liberação dos morfógenos contidos em seu interior que, induzem temporal e espacialmente a formação óssea/medular. / The aim of the present work was to correlate the cellular and tissue events with the expression of VEGF, BMP-7, RANKL and OPG during ectopic and orthotopic osteogenesis, induced by bone and dentin allogeneic matrix. Allogenic matrices obtained from femur and incisor of rats and demineralized in 0.6 N HCl were implanted into a intramuscular pocket and a 8mm-diameter bone defect in the skull. The radiographic and histomorphometric analysis of new bone formation, and immunohistochemistry and western blotting for VEGF, BMP, RANKL and OPG proteins, showed that: a) the total volume of the graft region in orthotopic site decreased 19% at 42 days b) in both graft types and implantation sites occurred formation of cartilaginous and bone tissues, c) in intramuscular sites, the resorption of allogenic matrix and remodeling of the new formed cartilage and bone were faster, in relation to orthotopic implantation sites; d) the increase in the volume density of blood vessels and in the number of osteoblasts/osteocytes and osteoclasts occurred simultaneously and was associated with greater reabsorption of the allogenic matrix and hematopoietic bone marrow formation; e) VEGF, BMP-7, RANKL, OPG proteins were expressed in chondrocytes, active osteoblasts, newly osteocytes confined and stromal cells located near the osteoblasts or in the surface of the reabsorbed matrix; and f) the VEGF, BMP-7, RANKL and OPG expression was higher in MO grafts than in the MD. The peak of expression of these proteins each occurred at 14 and 21 days in MO and 21 and 28 days in MD. We concluded that, the osteoinductive capacity of allogeneic demineralized matrix is related to matrix origin and implantation site and that the VEGF, BMP-7, RANKL and OPG proteins are associated with greater reabsorption of the implanted matrix, promoting rapid and continuous matrix-release morphogens that induces spatially and temporally the bone and bone marrow formation.